Hyderabad Endovascular Clinic Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 22-06-2024
- Paid Up Capital ₹ 0.50 M
as on 22-06-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.16 Cr
as on 22-06-2024
- Revenue 19.54%
(FY 2019)
- Profit 25.59%
(FY 2019)
- Ebitda 20.17%
(FY 2019)
- Net Worth 53.94%
(FY 2019)
- Total Assets 29.47%
(FY 2019)
About Hyderabad Endovascular Clinic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹1.16 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rupesh Bellap and Koppala Vikramaditya serve as directors at the Company.
- CIN/LLPIN
U85100TG2014PTC092197
- Company No.
092197
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hyderabad Endovascular Clinic?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupesh Bellap  | Director | 23-Oct-2021 | Current |
Koppala Vikramaditya  | Director | 07-Jan-2014 | Current |
Financial Performance and Corporate Structure Insights of Hyderabad Endovascular Clinic.
Hyderabad Endovascular Clinic Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 19.54% increase. The company also saw a substantial improvement in profitability, with a 25.59% increase in profit. The company's net worth Soared by an impressive increase of 53.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hyderabad Endovascular Clinic?
In 2019, Hyderabad Endovascular Clinic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sree Lakshmi Gayatri Hospitals Private LimitedActive 13 years 6 monthsKoppala Vikramaditya is a mutual person
Rade Ranch Private LimitedActive 13 years 9 monthsRupesh Bellap and Koppala Vikramaditya are mutual person
- Credo Business Commune Private LimitedActive 8 months 24 days
Rupesh Bellap and Koppala Vikramaditya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Siemens Financial Services Private Limited Creation Date: 26 Nov 2014 | ₹1.16 Cr | Satisfied |
How Many Employees Work at Hyderabad Endovascular Clinic?
Unlock and access historical data on people associated with Hyderabad Endovascular Clinic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hyderabad Endovascular Clinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyderabad Endovascular Clinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
